BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2021
View Archived Issues
Linking antiphospholipid antibodies to autoimmunity
Read More
Lipid dysregulation gives information on Parkinson's
Read More
Immune system, treatment, in kidney cancer
Read More
Moderna initiates phase I study of its next-generation COVID-19 vaccine, mRNA-1283
Read More
Multimorbid diseases cluster in predictable ways: study
Read More
Pliant completes phase I study of PLN-1474 and transfers the candidate to Novartis
Read More
First patients dosed in global phase I study of ADG-126
Read More
First patient dosed in phase I study of emricasan in mild symptomatic COVID-19
Read More
Arbutus receives regulatory approval for phase Ia/Ib trial of AB-836 in chronic HBV infection
Read More
Galmed initiates dosing in first-in-human phase I trial of Amilo-5MER
Read More
FDA clears IND for phase II study of CYTO-205 as treatment of mild COVID-19
Read More
AB-205 eliminates oral and gastrointestinal SRRT in adults undergoing HDT-AHCT
Read More
UCB describes new antimalarial compounds
Read More
KalVista Pharmaceuticals discovers FXIIa inhibitors
Read More
Otsuka Pharmaceutical, Taiho Pharmaceutical patent PTPN11 inhibitors
Read More
New anti-SIRP-alpha antibodies described by Elpiscience BioPharma
Read More
First-in-human results presented for R-552 in healthy adults
Read More
Biohaven Therapeutics identifies compounds targeting TDP-43
Read More
Study reveals dose finding for gevokizumab in oncology
Read More
THCVHS shows no signs of eye irritation in in vitro assay
Read More
French clearance for first-in-human study of PEP-010 in advanced solid tumors
Read More
Phase Ib data with VS-01 support advancement to phase IIa for acute on chronic liver failure
Read More
Corat gains clearances to begin phase Ib/II trial of COR-101 for COVID-19
Read More
HTI vaccines show promise for virus control without ART in patients with early HIV infection
Read More
Clinical trial collaboration supports new phase II study of Tabrecta and Nerlynx in breast cancer
Read More
Annovis reports phase IIa interim data on ANVS-401 in Parkinson's patients
Read More
MaaT reports phase II topline data on MaaT-013 in steroid-refractory GI acute GvHD
Read More